These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
65 related items for PubMed ID: 935645
1. Penetration of phenylacetic acid across the blood-cerebrospinal fluid barrier. Pedemonte WA, Mosnaim AD, Bulat M. Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):111-6. PubMed ID: 935645 [Abstract] [Full Text] [Related]
2. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis. Wong SL, Van Belle K, Sawchuk RJ. J Pharmacol Exp Ther; 1993 Feb; 264(2):899-909. PubMed ID: 8437131 [Abstract] [Full Text] [Related]
3. Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis: possible involvement of the monocarboxylic acid transport system. Deguchi Y, Nozawa K, Yamada S, Yokoyama Y, Kimura R. J Pharmacol Exp Ther; 1997 Feb; 280(2):551-60. PubMed ID: 9023263 [Abstract] [Full Text] [Related]
4. Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbits. Scism JL, Powers KM, Artru AA, Chambers AC, Lewis L, Adkison KK, Kalhorn TF, Shen DD. Drug Metab Dispos; 1997 Dec; 25(12):1337-46. PubMed ID: 9394022 [Abstract] [Full Text] [Related]
5. Interleukin-2 and blood brain barrier in cats: pharmacokinetics and tolerance following intrathecal and intravenous administration. Martin R, Schwuléra U, Menke G, Rudolph W, Buch K, Fasold H, Lissner R, Thrun A, Krauseneck P, Bogdahn U. Eur Cytokine Netw; 1992 Dec; 3(4):399-406. PubMed ID: 1421012 [Abstract] [Full Text] [Related]
6. In vivo evidence for carrier-mediated efflux transport of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system. Takasawa K, Terasaki T, Suzuki H, Sugiyama Y. J Pharmacol Exp Ther; 1997 Apr; 281(1):369-75. PubMed ID: 9103519 [Abstract] [Full Text] [Related]
7. Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man. Karoum F, Potkin S, Chuang LW, Murphy DL, Liebowitz MR, Wyatt RJ. Biol Psychiatry; 1984 Feb; 19(2):165-78. PubMed ID: 6713036 [Abstract] [Full Text] [Related]
8. Facilitated transport of cefodizime into the rat central nervous system. Matsushita H, Suzuki H, Sugiyama Y, Sawada Y, Iga T, Kawaguchi Y, Hanano M. J Pharmacol Exp Ther; 1991 Nov; 259(2):620-5. PubMed ID: 1941610 [Abstract] [Full Text] [Related]
9. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa. Extein I, Van Woert M, Roth RH, Bowers MB. Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447 [Abstract] [Full Text] [Related]
10. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid. Andersson H, von Essen C, Roos BE. Acta Pharmacol Toxicol (Copenh); 1973 Apr; 32(1):129-38. PubMed ID: 4741033 [No Abstract] [Full Text] [Related]
11. Cerebrospinal fluid probenecid studies: a reinterpretation. Cowdry RW, Ebert MH, van Kammen DP, Post RM, Goodwin FK. Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100 [Abstract] [Full Text] [Related]
12. CSF homovanillic acid: effects of probenecid and alpha-methyltyrosine. Bowers MB. Life Sci I; 1970 Jun 15; 9(12):691-4. PubMed ID: 5473333 [No Abstract] [Full Text] [Related]
13. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. Sabelli HC, Fawcett J, Gusovsky F, Javaid JI, Wynn P, Edwards J, Jeffriess H, Kravitz H. J Clin Psychiatry; 1986 Feb 15; 47(2):66-70. PubMed ID: 3944066 [Abstract] [Full Text] [Related]
14. Conjugation of phenylacetic acid and m- and p-hydroxyphenylacetic acids in the rat striatum. Dyck LE, Durden DA, Boulton AA. Life Sci; 1993 Feb 15; 53(11):901-9. PubMed ID: 8366757 [Abstract] [Full Text] [Related]
15. Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin. Pfeifer G, Frenkel C, Entzian W. Int J Clin Pharmacol Res; 1985 Feb 15; 5(3):171-4. PubMed ID: 4018950 [Abstract] [Full Text] [Related]
16. The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process. Tachikawa M, Kasai Y, Takahashi M, Fujinawa J, Kitaichi K, Terasaki T, Hosoya K. J Neurochem; 2008 Oct 15; 107(2):432-42. PubMed ID: 18752646 [Abstract] [Full Text] [Related]
17. Plasma and cerebrospinal fluid concentration of phenylacetic acid in humans and monkeys. Karoum F, Chuang LW, Mosnaim AD, Staub RA, Wyatt RJ. J Chromatogr Sci; 1983 Dec 15; 21(12):546-50. PubMed ID: 6420430 [Abstract] [Full Text] [Related]
18. Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration. Liu X, Smith BJ, Chen C, Callegari E, Becker SL, Chen X, Cianfrogna J, Doran AC, Doran SD, Gibbs JP, Hosea N, Liu J, Nelson FR, Szewc MA, Van Deusen J. Drug Metab Dispos; 2006 Sep 15; 34(9):1443-7. PubMed ID: 16760229 [Abstract] [Full Text] [Related]
19. Antibiotic prophylaxis in cerebrospinal fluid shunting: reassessment of Cefotiam penetration into human CSF. Knoop M, Schütze M, Piek J, Drewelow B, Mundkowski R. Zentralbl Neurochir; 2007 Feb 15; 68(1):14-8. PubMed ID: 17487803 [Abstract] [Full Text] [Related]
20. [Effect of ethanol and probenecid on the excretory function of the cerebral choroid plexus in rats]. Borisenko SA. Biull Eksp Biol Med; 1989 Mar 15; 107(3):312-4. PubMed ID: 2713469 [Abstract] [Full Text] [Related] Page: [Next] [New Search]